Valneva SE (VALN) Cash from Operations (QoQ) (2021 - 2026)
Valneva SE (VALN) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.83% |
| Dec 31, 2025 | -66.65% |
| Sep 30, 2025 | -505.70% |
| Jun 30, 2025 | 65.96% |
| Mar 31, 2025 | -197.09% |
| Dec 31, 2024 | 179.43% |
| Sep 30, 2024 | 72.78% |
| Jun 30, 2024 | -30.20% |
| Mar 31, 2024 | 57.65% |
| Dec 31, 2023 | -100.10% |
| Sep 30, 2023 | 199.83% |
| Jun 30, 2023 | -270,963.10% |
| Mar 31, 2023 | 58.02% |
| Dec 31, 2022 | 36.07% |
| Sep 30, 2022 | -22.69% |
| Jun 30, 2022 | -170.23% |
| Mar 31, 2022 | -166.37% |
| Dec 31, 2021 | 185.20% |
| Sep 30, 2021 | -229.37% |
| Jun 30, 2021 | -24.87% |